Nomura Holdings Inc Ironwood Pharmaceuticals Inc Transaction History

Nomura Holdings Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $1.64 Million - $2.11 Million	-151,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $1.8 Million - $2.1 Million	151,000 New	151,000 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $240,924 - $310,877	-23,713 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $62,294 - $81,727	-6,891 Reduced 22.52%	23,713 $265,000
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $276,966 - $373,368	30,604 New	30,604 $350,000
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $1.2 Million - $1.43 Million	-133,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $807,208 - $1.06 Million	88,316 Added 197.65%	133,000 $1.37 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $383,388 - $626,022	44,684 New	44,684 $450,000
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $550,963 - $848,098	-66,622 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $121,789 - $251,853	15,614 Added 30.61%	66,622 $688,000
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $1.1 Million - $1.35 Million	-76,757 Reduced 60.08%	51,008 $931,000
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $1.51 Million - $2.07 Million	127,765 New	127,765 $2.27 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $663M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.